Exchange Change
After nearly three decades of entrenched opposition to funding programs that allow drug users to obtain free sterile syringes, the U.S. Congress in January…
VA’s Hep Crisis
The newest class of antiretroviral drugs has sparked a revolution in the treatment of hepatitis C, but for the Department of Veterans Affairs, this…
Red State Blues
As A&U reported in the June issue, the rise in HIV and hepatitis C (HCV) diagnoses in Scott County, Indiana, has put the state…
The Price of War
Cost of treatment and prevention in the war on viral hepatitis was the overriding theme of the first World Hepatitis Summit, which drew more…
HCV Under the Radar
It’s desk-clearing time for 2015 and time to visit some under-reported hepatitis C-related news. Hep C has been in the news quite a bit…
Affairs of the Heart
It is well known that people with hepatitis C virus (HCV) are at risk for liver damage, but the results of two new studies…
Be About It: Hep B in Asian/Pacific Islander Communities
Talking About It
A documentary put human faces on hep B in Asian-American communities
by Larry Buhl
According to the U.S. Centers for Disease Control and Prevention…
Equal HCV Treatment Benefits
A press conference at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) offered two main takeaways: that the new generation of oral direct-acting antiviral agents (DAAs) are highly effective and safe, and…
Process of Elimination
As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s…
Medicaid HCV Blockade
Denial
Many states restrict DAA coverage to the sickest of hep C patients
by Larry Buhl
When direct-acting antiretrovirals (DAAs) for hepatitis C were new, some private…



















